[Deep brain stimulation using simultaneous stereotactic electrode placement: an alternative to conventional...

Area of Science:

• Neurosurgery
• Neurology
• Medical Devices

Background:

• Deep brain stimulation (DBS) is a proven treatment for movement disorders like idiopathic Parkinson's disease (IPD).
• Stereotactic frames are essential for precise DBS electrode placement.
• The Starfix® platform offers a novel approach to stereotactic surgery for IPD.

Purpose of the Study:

• To compare the surgical outcomes of IPD patients using conventional stereotactic frames versus the Starfix® platform.
• To evaluate the efficacy and safety of DBS implantation with both stereotactic systems.

Main Methods:

• Retrospective analysis of 60 IPD patients (31 conventional, 29 Starfix®).
• Comparison of surgery time, Unified Parkinson's Disease Rating Scale III (UPDRS/III) scores, and medication dosages (L-dopa, LED).
• Data collected pre-operatively and at 4 weeks, 12 weeks, 6 months, and 1 year post-operatively.

Main Results:

• Both methods significantly improved IPD symptoms, with comparable UPDRS III score reductions (69.6% conventional vs. 72.4% Starfix®).
• Significant reductions in L-dopa and LED were observed in both groups post-surgery.
• The Starfix® platform demonstrated a significant reduction in surgical time and allowed simultaneous electrode positioning.

Conclusions:

• Both conventional and Starfix® stereotactic frames are reliable and safe for DBS electrode placement in IPD.
• The Starfix® platform offers advantages in surgical efficiency and individualized patient care.
• Logistical uncoupling of planning and surgery enhances the benefits of individualized stereotactic procedures.